Phase
Condition
Hormone Deficiencies
Diabetes (Pediatric)
Primary Insulin Hypersecretion
Treatment
Dexcom G6 continuous glucose monitor
Clinical Study ID
Ages 24-3 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age: 0-90 days old
Gestational Age: > 28 weeks gestational age
Diagnosis of hyperinsulinism based on critical sample and/or glucagon challenge
Exclusion
Exclusion Criteria:
Diffuse skin disease such that placement of a Dexcom G6 sensor would be difficult tosecure
Infants colonized or infected with multi-drug resistant organisms (i.e. MRSA, VRE,ESBL producing bacteria)
Infants on hypothermic protocols
Infants expected to remain in the NICU <24 hours
Infants enrolled in a competing clinical trial
Family/team have decided to limit or redirect from aggressive NICU technologicalsupport
Ward of the state
Study Design
Connect with a study center
Miller Children's Hospital
Long Beach, California 90806
United StatesSite Not Available
Miller Children's Hospital
Long Beach 5367929, California 5332921 90806
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.